よむ、つかう、まなぶ。
【資料No.1】2.4_非臨床試験の概括資料 (32 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_26901.html |
| 出典情報 | 薬事・食品衛生審議会 薬事分科会(令和4年度第3回 7／20)、医薬品第二部会(令和4年度第6回 7／20)（合同開催）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
S-217622
2.4 非臨床の概括評価
27. Chernoff N, Rogers JM, Turner CI, Francis BM. Significance of supernumerary ribs in rodent
developmental toxicity studies: postnatal persistence in rats and mice. Fundam Appl Toxicol
1991;17;448–53.
28. Matsuzawa T, Nakata M, Goto I, Tsushima M. Dietary deprivation induces fetal loss and abortion in
rabbits. Toxicology 1981;22:255-9.
29. Ouimet M, Barrett TJ, Fisher EA. HDL and reverse cholesterol transport. Circ Res 2019;124:1505-18.
30. Glomset JA. The Plasma Lecithin:cholesterol Acyltransferase Reaction. J Lipid Res 1968;9(2):155-67.
31. Remaley AT, Amar M, Sviridov D. HDL-replacement therapy: Mechanism of action, types of agents
and potential clinical indications. Expert Rev Cardiovasc Ther 2008;6(9):1203-15.
32. Rousset X, Vaisman B, Amar M, Sethi AA, Remaley AT. Lecithin:cholesterol acyltransferase: from
biochemistry to role in cardiovascular disease. Curr Opin Endocrinol Diabetes Obes 2009;16(2):16371.
33. Yamamoto S, Narita I, Kotani K. The Macrophage and its related cholesterol efflux as a HDL function
index in atherosclerosis. Clin Chim Acta 2016;457:117-22.
34. Furusyo N, Ai M, Okazaki M, et al. Serum cholesterol and triglyceride reference ranges of twenty
lipoprotein subclasses for healthy Japanese men and women. Atherosclerosis 2013;231: 238-45.
35. Barter PJ, Brewer HB, Chapman MJ, et al. Cholesteryl ester transfer protein: A novel target for raising
HDL and inhibiting atherosclerosis. Arterioscler Thromb Vasc Biol 2003;23:160-7.
32
2.4 非臨床の概括評価
27. Chernoff N, Rogers JM, Turner CI, Francis BM. Significance of supernumerary ribs in rodent
developmental toxicity studies: postnatal persistence in rats and mice. Fundam Appl Toxicol
1991;17;448–53.
28. Matsuzawa T, Nakata M, Goto I, Tsushima M. Dietary deprivation induces fetal loss and abortion in
rabbits. Toxicology 1981;22:255-9.
29. Ouimet M, Barrett TJ, Fisher EA. HDL and reverse cholesterol transport. Circ Res 2019;124:1505-18.
30. Glomset JA. The Plasma Lecithin:cholesterol Acyltransferase Reaction. J Lipid Res 1968;9(2):155-67.
31. Remaley AT, Amar M, Sviridov D. HDL-replacement therapy: Mechanism of action, types of agents
and potential clinical indications. Expert Rev Cardiovasc Ther 2008;6(9):1203-15.
32. Rousset X, Vaisman B, Amar M, Sethi AA, Remaley AT. Lecithin:cholesterol acyltransferase: from
biochemistry to role in cardiovascular disease. Curr Opin Endocrinol Diabetes Obes 2009;16(2):16371.
33. Yamamoto S, Narita I, Kotani K. The Macrophage and its related cholesterol efflux as a HDL function
index in atherosclerosis. Clin Chim Acta 2016;457:117-22.
34. Furusyo N, Ai M, Okazaki M, et al. Serum cholesterol and triglyceride reference ranges of twenty
lipoprotein subclasses for healthy Japanese men and women. Atherosclerosis 2013;231: 238-45.
35. Barter PJ, Brewer HB, Chapman MJ, et al. Cholesteryl ester transfer protein: A novel target for raising
HDL and inhibiting atherosclerosis. Arterioscler Thromb Vasc Biol 2003;23:160-7.
32